![]() |
市场调查报告书
商品编码
1490757
2024-2028年全球肿瘤消融市场Global Tumor Ablation Market 2024-2028 |
2023-2028年肿瘤消融市场预估为14.328亿美元,预测期内复合年增长率为14.62%。
该报告包括对肿瘤消融市场的总体分析、市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括人们对微创治疗的偏好、对个人化医疗和标靶治疗的持续重视以及对门诊癌症治疗的日益关注。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 14.42% |
复合年增长率 | 14.62% |
增量 | 1,432.8 百万美元 |
研究指出,越来越多采用影像导引肿瘤消融是推动未来几年肿瘤消融市场成长的关键因素之一。此外,多模态肿瘤消融方法的开拓以及人工智慧(AI)与肿瘤消融平台的整合将带来巨大的市场需求。
The tumor ablation market is forecasted to grow by USD 1432.8 mn during 2023-2028, accelerating at a CAGR of 14.62% during the forecast period. The report on the tumor ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing preference for minimally invasive procedures, continued emphasis on personalized medicine and targeted therapies, and rising focus on cancer treatment in outpatient settings.
Technavio's tumor ablation market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 14.42% |
CAGR | 14.62% |
Incremental Value | $1432.8mn |
By Type
By Application
By Geographical Landscape
This study identifies the increasing adoption of image-guided tumor ablation as one of the prime reasons driving the tumor ablation market growth during the next few years. Also, development of multimodal tumor ablation approaches and integration of artificial intelligence (AI) into tumor ablation platforms will lead to sizable demand in the market.
The report on the tumor ablation market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tumor ablation market vendors that include Alpinion Medical Systems Co. Ltd., AngioDynamics Inc., Apyx Medical Corp., Bioventus LLC, Boston Scientific Corp., BVM Medical Ltd., EDAP TMS, ForTec Medical, IceCure Medical Ltd., Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Monteris Medical Corp., Olympus Europa SE and Co. KG, Profound Medical Corp., Smith and Nephew plc, Stryker Corp., TechsoMed Medical Technologies Ltd., Terumo Corp., and Varian Medical Systems Inc.. Also, the tumor ablation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: